NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) — E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it served as exclusive financial advisor in the strategic business combination between Glucotrack, Inc. (Nasdaq: GCTK) and Lōkahi Therapeutics
Appointment positions the volumetric modular AI-native robotic production stack for U.S. public markets as EcoModular scales against a robust, significant pipeline.
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) — E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced the appointment of Adam Kerbis as Managing Director, Head of SPAC Investment Banking
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) — E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced the appointment of Adam Kerbis as Managing Director, Head of SPAC Investment Banking,
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) — E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced the promotion of Geoffrey D. Liddy to Chief Operating Officer.
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) — E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the sole placement agent in connection with a $4.0 million private placement for HCW Biologics Inc.
